REFILE-LYRA THERAPEUTICS, INC. : H.C. WAINWRIGHT ADJUSTS TARGET PRICE TO $16 FROM $2 TO REFLECT 1-FOR-50 REVERSE STOCK SPLIT (CLARIFIES PT IS SPLIT ADJUSTED)

Reuters · 2d ago

Please log in to view news